96 related articles for article (PubMed ID: 26717877)
1. Galectin-9 suppresses the proliferation of gastric cancer cells in vitro.
Takano J; Morishita A; Fujihara S; Iwama H; Kokado F; Fujikawa K; Fujita K; Chiyo T; Tadokoro T; Sakamoto T; Nomura T; Tani J; Miyoshi H; Yoneyama H; Kobara H; Mori H; Niki T; Hirashima M; Masaki T
Oncol Rep; 2016 Feb; 35(2):851-60. PubMed ID: 26717877
[TBL] [Abstract][Full Text] [Related]
2. Galectin-9 suppresses cholangiocarcinoma cell proliferation by inducing apoptosis but not cell cycle arrest.
Kobayashi K; Morishita A; Iwama H; Fujita K; Okura R; Fujihara S; Yamashita T; Fujimori T; Kato K; Kamada H; Niki T; Hirashima M; Okano K; Suzuki Y; Masaki T
Oncol Rep; 2015 Oct; 34(4):1761-70. PubMed ID: 26260906
[TBL] [Abstract][Full Text] [Related]
3. Effects of galectin-9 on apoptosis, cell cycle and autophagy in human esophageal adenocarcinoma cells.
Akashi E; Fujihara S; Morishita A; Tadokoro T; Chiyo T; Fujikawa K; Kobara H; Mori H; Iwama H; Okano K; Suzuki Y; Niki T; Hirashima M; Masaki T
Oncol Rep; 2017 Jul; 38(1):506-514. PubMed ID: 28586026
[TBL] [Abstract][Full Text] [Related]
4. Galectin-9: An anticancer molecule for gallbladder carcinoma.
Tadokoro T; Morishita A; Fujihara S; Iwama H; Niki T; Fujita K; Akashi E; Mimura S; Oura K; Sakamoto T; Nomura T; Tani J; Miyoshi H; Yoneyama H; Himoto T; Hirashima M; Masaki T
Int J Oncol; 2016 Mar; 48(3):1165-74. PubMed ID: 26797414
[TBL] [Abstract][Full Text] [Related]
5. Galectin‑9 suppresses the tumor growth of colon cancer
Morishita A; Nomura K; Tani J; Fujita K; Iwama H; Takuma K; Nakahara M; Tadokoro T; Oura K; Chiyo T; Fujihara S; Niki T; Hirashima M; Nishiyama A; Himoto T; Masaki T
Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33907832
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA profiles during galectin-9-induced apoptosis of pancreatic cancer cells.
Okura R; Fujihara S; Iwama H; Morishita A; Chiyo T; Watanabe M; Hirose K; Kobayashi K; Fujimori T; Kato K; Kamada H; Kobara H; Mori H; Niki T; Hirashima M; Okano K; Suzuki Y; Masaki T
Oncol Lett; 2018 Jan; 15(1):407-414. PubMed ID: 29387226
[TBL] [Abstract][Full Text] [Related]
7. Galectin-8 promotes migration and proliferation and prevents apoptosis in U87 glioblastoma cells.
Metz C; Döger R; Riquelme E; Cortés P; Holmes C; Shaughnessy R; Oyanadel C; Grabowski C; González A; Soza A
Biol Res; 2016 Jul; 49(1):33. PubMed ID: 27459991
[TBL] [Abstract][Full Text] [Related]
8. Induction of apoptosis by Galectin-9 in liver metastatic cancer cells: In vitro study.
Tadokoro T; Fujihara S; Chiyo T; Oura K; Samukawa E; Yamana Y; Fujita K; Mimura S; Sakamoto T; Nomura T; Tani J; Yoneyama H; Morishita A; Himoto T; Iwama H; Niki T; Hirashima M; Masaki T
Int J Oncol; 2017 Aug; 51(2):607-614. PubMed ID: 28656219
[TBL] [Abstract][Full Text] [Related]
9. Antitumor Effect of Galectin-9 on Cell Proliferation and Tumor Growth of Human Duodenal Adenocarcinoma Cells.
Kono T; Fujihara S; Oura K; Iwama H; Fujita K; Fujita N; Takuma K; Ono M; Namima D; Yamana H; Chiyo T; Kobayashi K; Kamada H; Kobara H; Ono M; Niki T; Hirashima M; Masaki T
Anticancer Res; 2023 Aug; 43(8):3769-3777. PubMed ID: 37500141
[TBL] [Abstract][Full Text] [Related]
10. KRC-408, a novel c-Met inhibitor, suppresses cell proliferation and angiogenesis of gastric cancer.
Hong SW; Jung KH; Park BH; Zheng HM; Lee HS; Choi MJ; Yun JI; Kang NS; Lee J; Hong SS
Cancer Lett; 2013 May; 332(1):74-82. PubMed ID: 23348694
[TBL] [Abstract][Full Text] [Related]
11. Role of downregulation of galectin-9 in the tumorigenesis of gastric cancer.
Yang J; Zhu L; Cai Y; Suo J; Jin J
Int J Oncol; 2014 Sep; 45(3):1313-20. PubMed ID: 24919464
[TBL] [Abstract][Full Text] [Related]
12. Galectin-9 exhibits anti-myeloma activity through JNK and p38 MAP kinase pathways.
Kobayashi T; Kuroda J; Ashihara E; Oomizu S; Terui Y; Taniyama A; Adachi S; Takagi T; Yamamoto M; Sasaki N; Horiike S; Hatake K; Yamauchi A; Hirashima M; Taniwaki M
Leukemia; 2010 Apr; 24(4):843-50. PubMed ID: 20200560
[TBL] [Abstract][Full Text] [Related]
13. Galectin-9 Induces Mitochondria-Mediated Apoptosis of Esophageal Cancer In Vitro and In Vivo in a Xenograft Mouse Model.
Chiyo T; Fujita K; Iwama H; Fujihara S; Tadokoro T; Ohura K; Matsui T; Goda Y; Kobayashi N; Nishiyama N; Yachida T; Morishita A; Kobara H; Mori H; Niki T; Hirashima M; Himoto T; Masaki T
Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31146370
[TBL] [Abstract][Full Text] [Related]
14. Reduced galectin-3 expression is an indicator of unfavorable prognosis in gastric cancer.
Okada K; Shimura T; Suehiro T; Mochiki E; Kuwano H
Anticancer Res; 2006; 26(2B):1369-76. PubMed ID: 16619546
[TBL] [Abstract][Full Text] [Related]
15. Galectin-9 suppresses the growth of hepatocellular carcinoma via apoptosis in vitro and in vivo.
Fujita K; Iwama H; Sakamoto T; Okura R; Kobayashi K; Takano J; Katsura A; Tatsuta M; Maeda E; Mimura S; Nomura T; Tani J; Miyoshi H; Morishita A; Yoneyama H; Yamana Y; Himoto T; Okano K; Suzuki Y; Niki T; Hirashima M; Masaki T
Int J Oncol; 2015; 46(6):2419-30. PubMed ID: 25823465
[TBL] [Abstract][Full Text] [Related]
16. Galectin-9 suppresses tumor metastasis by blocking adhesion to endothelium and extracellular matrices.
Nobumoto A; Nagahara K; Oomizu S; Katoh S; Nishi N; Takeshita K; Niki T; Tominaga A; Yamauchi A; Hirashima M
Glycobiology; 2008 Sep; 18(9):735-44. PubMed ID: 18579572
[TBL] [Abstract][Full Text] [Related]
17. Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers.
Sakakura C; Hasegawa K; Miyagawa K; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Yazumi S; Yamagishi H; Okanoue T; Chiba T; Hagiwara A
Clin Cancer Res; 2005 Sep; 11(18):6479-88. PubMed ID: 16166423
[TBL] [Abstract][Full Text] [Related]
18. 3,3'-Diindolylmethane suppresses the growth of gastric cancer cells via activation of the Hippo signaling pathway.
Li XJ; Park ES; Park MH; Kim SM
Oncol Rep; 2013 Nov; 30(5):2419-26. PubMed ID: 24008339
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor C stimulates progression of human gastric cancer via both autocrine and paracrine mechanisms.
Kodama M; Kitadai Y; Tanaka M; Kuwai T; Tanaka S; Oue N; Yasui W; Chayama K
Clin Cancer Res; 2008 Nov; 14(22):7205-14. PubMed ID: 19010837
[TBL] [Abstract][Full Text] [Related]
20. Effects of the proteasome inhibitor bortezomib alone and in combination with chemotherapeutic agents in gastric cancer cell lines.
Bae SH; Ryoo HM; Kim MK; Lee KH; Sin JI; Hyun MS
Oncol Rep; 2008 Apr; 19(4):1027-32. PubMed ID: 18357392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]